During Tuesday’s Current trade, Shares of Cree, Inc. (NASDAQ:CREE), gain 1.68% to $24.15.
Cree, Inc. ( CREE) introduces new KR8™ and LR6™ LED downlights, designed to deliver better lighting performance and better value for new and existing commercial spaces. The new KR8 downlight expands the KR Series by adding Cree’s first eight-inch downlight, and features Cree WaveMax™ Technology and Cree TrueWhite® Technology. This revolutionary combination brings even more beautiful light through optical efficiency, precise beam control and long product life to higher ceiling applications, such as theaters, airports and auditoriums. Cree also declares the newest generation of its pioneering, market leading LR6 downlight, which provides even better light quality at a lower price. These new LED lighting solutions further enhance Cree’s product leadership in the commercial downlight market.
With the new KR8 downlight, Cree’s architectural downlight portfolio now addresses ceiling heights from eight feet up to 40 feet. Additionally, the KR8 downlight covers most commercial and retail applications with 6,000 and 8,000 lumen outputs, achieving what other high-lumen output LED downlights have not been able to deliver with more light, a range of beam spreads and unrivaled optical control. The specification-grade downlight integrates Cree’s WaveMax Technology and uses a unique dual optic design that enables industry-leading precision with beam angles as tight as 15 degrees, providing unmatched light uniformity and better color performance with a 90-plus CRI.
Cree, Inc. provides lighting-class light emitting diode (LED), lighting, and semiconductor products for power and radio-frequency (RF) applications in the United States, China, Europe, South Korea, Japan, Malaysia, Taiwan, and internationally. Its Lighting Products segment offers LED lighting systems and bulbs for use in settings, such as office and retail space, restaurants and hospitality, schools and universities, manufacturing, healthcare, airports, municipal, residential, street lighting and parking structures, and other applications This segment sells its products to distributors, retailers, and customers.
Shares of AllianceBernstein Income Fund Inc. (NYSE:ACG), declined -0.13% to $7.89, during its current trading session.
Alliance Growers Corp. (ACG) declares that Charles Carleton has decided to step down as President and Chief Executive Officer of the Company. Mr. Carleton will remain as a valuable member of the Company’s Board of Directors.
The Company is happy to declare that Paul Karroll has been designated as President and CEO in Mr. Carleton’s place. Mr. Karroll has been a Senior Business Analyst with Trichome Consulting Services since 2012, which specializes in MMPR manufacturing, technology, distributors and retail organizations. He is a forward thinking business strategist with a 20+ year track record of successes in key administration, training and operations. He has extensive knowledge in account development and new market penetration in highly competitive and volatile sectors. He is adept at anticipating and responding to market trends and identifying new ways to add value and profitability. With noteworthy knowledge and experience in the North American cannabis industry, developing marketing and sales programs plus analyzing industry trends for future business development, Mr. Karroll will play an integral role in the Company’s future.
BioTelemetry, Inc. (NASDAQ:BEAT), during its Tuesday’s current trading session gained 4.94% to $12.33.
BioTelemetry, Inc. (BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, declared that Board member Ronald A. Ahrens will retire after 7 years of service to BioTelemetry shareholders.
Mr. Ahrens joined BioTelemetry’s Board in 2008 and has served as Chairman of the Compensation Committee since 2009. Preceding to joining BioTelemetry, Mr. Ahrens had extensive experience as a Director and Board consultant, most recently serving as Vice Chairman of Temptime Corporation from 2004 to 2013 and as Chairman of the Compensation Committee of VIASYS Healthcare Inc. from 2001 to 2007. Mr. Ahrens has over 40 years of administration experience in the healthcare industry, having held various leadership positions with Merck & Co., counting President of Merck Consumer Healthcare Group Worldwide and Executive Vice President of Merck Consumer Healthcare Group International. Mr. Ahrens received an undergraduate degree from Concordia College and a Masters in Sacred Theology from Concordia Seminary.
BioTelemetry, Inc. provides cardiac monitoring, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates in three segments: Patient Services, Product, and Research Services.
Finally, Beazer Homes USA, Inc. (NYSE:BZH), gained 0.64%, to $13.90.
Beazer Homes USA, Inc. (BZH) will present at the 23rd Annual Deutsche Bank Leveraged Finance Conference in Scottsdale, AZ on Wednesday September 30, 2015 at 4:15 pm MST or 7:15 pm EDT.
Beazer Homes USA, Inc. designs, builds, and sells single-family and multi-family homes in the United States. It provides homes for entry-level, move-up, or retirement-oriented buyers. The company sells its homes under the Beazer Homes brand name through commissioned new home sales counselors and independent brokers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
